Cargando…
P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428240/ http://dx.doi.org/10.1097/01.HS9.0000968364.56569.fb |
| _version_ | 1785090420065173504 |
|---|---|
| author | Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie MI, Jian‑qing Wang, Jin |
| author_facet | Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie MI, Jian‑qing Wang, Jin |
| author_sort | Liu, Weiyang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428240 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282402023-08-17 P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie MI, Jian‑qing Wang, Jin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428240/ http://dx.doi.org/10.1097/01.HS9.0000968364.56569.fb Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie MI, Jian‑qing Wang, Jin P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_full | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_fullStr | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_full_unstemmed | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_short | P363: A PHASE II STUDY OF FLUMATINIB WITH CHEMOTHERAPY FOR NEWLY DIAGNOSED PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: UPDATED RESULTS FROM RJ-ALL2020.2A TRIAL |
| title_sort | p363: a phase ii study of flumatinib with chemotherapy for newly diagnosed ph/bcr-abl1-positive acute lymphoblastic leukemia in adults: updated results from rj-all2020.2a trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428240/ http://dx.doi.org/10.1097/01.HS9.0000968364.56569.fb |
| work_keys_str_mv | AT liuweiyang p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT liuyuanfang p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT zhuyongmei p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT wengxiangqin p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT wangcheng p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT ouyangwanyan p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT xujie p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT mijianqing p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial AT wangjin p363aphaseiistudyofflumatinibwithchemotherapyfornewlydiagnosedphbcrabl1positiveacutelymphoblasticleukemiainadultsupdatedresultsfromrjall20202atrial |